During the past decade, SMG-SNU Boramae Medical Center conducted 142 clinical trials. In the 10-year time frame, 142 clinical trials started and 31 clinical trials were completed, i.e. on average, 21.8% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 22 clinical trials were completed. i.e. 36.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SMG-SNU Boramae Medical Center" #1 sponsor was "Seoul National University Hospital" with 58 trials, followed by "SMG-SNU Boramae Medical Center" with 17 trials sponsored, "Hoffmann-La Roche" with 11 trials sponsored, "Gilead Sciences" with 9 trials sponsored and "Pfizer" with 9 trials sponsored. Other sponsors include 92 different institutions and companies that sponsored additional 66 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SMG-SNU Boramae Medical Center" #1 collaborator was "SMG-SNU Boramae Medical Center" with 26 trials as a collaborator, "Seoul National University Bundang Hospital" with 8 trials as a collaborator, "Hallym University Medical Center" with 5 trials as a collaborator, "Seoul National University Boramae Hospital" with 5 trials as a collaborator and "Chonnam National University Hospital" with 4 trials as a collaborator. Other collaborators include 141 different institutions and companies that were collaborators in the rest 104 trials.

According to Clinical.Site data, the most researched conditions in "SMG-SNU Boramae Medical Center" are "Coronary Artery Disease" (8 trials), "Breast Cancer" (7 trials), "Rheumatoid Arthritis" (6 trials), "Gastric Cancer" (5 trials) and "Chronic Hepatitis B" (4 trials). Many other conditions were trialed in "SMG-SNU Boramae Medical Center" in a lesser frequency.

Most popular intervention types in "SMG-SNU Boramae Medical Center" are "Drug" (124 trials), "Other" (22 trials), "Procedure" (20 trials), "Device" (18 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Cilostazol" (3 trials), "Cisplatin" (3 trials), "Filgotinib" (3 trials) and "Guselkumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "SMG-SNU Boramae Medical Center" are 193 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "SMG-SNU Boramae Medical Center". 2 are not yet recruiting, 17 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 108 completed trials in SMG-SNU Boramae Medical Center, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in SMG-SNU Boramae Medical Center, 8 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 29 trials, and there were also 38 trials that are defined as “Not Applicable".